{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T18:57:42Z","timestamp":1725735462461},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lipoprotein-associated phospholipase A<jats:sub>2<\/jats:sub> (Lp-PLA<jats:sub>2<\/jats:sub>) is a unique circulating phospholipase with inflammatory and oxidative activities and the limited data regarding the relationship between Lp-PLA<jats:sub>2<\/jats:sub> and cognitive impairment are conflicted. We conducted a cross-sectional study including 1,374 Chinese adults recruited from 2010 to 2011, aiming to evaluate the relationship between Lp-PLA<jats:sub>2<\/jats:sub> levels and the prevalence of cognitive impairment in a Chinese community-based population. Participants underwent standardized evaluation. Serum Lp-PLA2 mass was measured by ELISA. Cognition status was evaluated via the Mini-Mental Status Exam (MMSE) and cognitive impairment was identified as MMSE &lt;24. Multivariable logistic regression models were used to assess the associations of Lp-PLA<jats:sub>2<\/jats:sub> mass with cognitive impairment. Lp-PLA<jats:sub>2<\/jats:sub> mass was significantly associated with the prevalence of cognitive impairment after adjusting for other potential confounding factors (compared with the first quartile, adjusted ORs of the second, third, and fourth quartile were 2.058 (95% CI, 0.876\u20134.835), 2.834 (95% CI, 1.255\u20136.398), and 4.882 (95% CI, 2.212\u201310.777), p\u2009&lt;\u20090.0001). In conclusion, elevated level of Lp-PLA<jats:sub>2<\/jats:sub> mass was independently associated with the prevalence of cognitive impairment in Chinese adults.<\/jats:p>","DOI":"10.1038\/srep33073","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T12:15:27Z","timestamp":1473423327000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Higher Levels of Lipoprotein Associated Phospholipase A2 is associated with Increased Prevalence of Cognitive Impairment: the APAC Study"],"prefix":"10.1038","volume":"6","author":[{"given":"Ruixuan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"BFsrep33073_CR1","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","volume":"375","author":"PLASC Lp","year":"2010","unstructured":"Lp, P. L. A. S. C. et al. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet 375, 1536\u20131544, doi: 10.1016\/S0140-6736(10)60319-4 (2010).","journal-title":"Lancet"},{"key":"BFsrep33073_CR2","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","volume":"343","author":"CJ Packard","year":"2000","unstructured":"Packard, C. J. et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. The New England journal of medicine 343, 1148\u20131155, doi: 10.1056\/NEJM200010193431603 (2000).","journal-title":"The New England journal of medicine"},{"key":"BFsrep33073_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1586\/14737159.7.5.511","volume":"7","author":"JF Carlquist","year":"2007","unstructured":"Carlquist, J. F., Muhlestein, J. B. & Anderson, J. L. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target. Expert review of molecular diagnostics 7, 511\u2013517, doi: 10.1586\/14737159.7.5.511 (2007).","journal-title":"Expert review of molecular diagnostics"},{"key":"BFsrep33073_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.20721","volume":"59","author":"M van Oijen","year":"2006","unstructured":"van Oijen, M. et al. Lipoprotein-associated phospholipase A2 is associated with risk of dementia. Annals of neurology 59, 139\u2013144, doi: 10.1002\/ana.20721 (2006).","journal-title":"Annals of neurology"},{"key":"BFsrep33073_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.atherosclerosis.2014.04.032","volume":"235","author":"AL Fitzpatrick","year":"2014","unstructured":"Fitzpatrick, A. L. et al. Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study. Atherosclerosis 235, 384\u2013391, doi: 10.1016\/j.atherosclerosis.2014.04.032 (2014).","journal-title":"Atherosclerosis"},{"key":"BFsrep33073_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/archneurol.2011.670","volume":"69","author":"TM van Himbergen","year":"2012","unstructured":"van Himbergen, T. M. et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study. Archives of neurology 69, 594\u2013600, doi: 10.1001\/archneurol.2011.670 (2012).","journal-title":"Archives of neurology"},{"key":"BFsrep33073_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/01.ATV.0000201289.83256.cf","volume":"26","author":"I Kardys","year":"2006","unstructured":"Kardys, I. et al. Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: the Rotterdam Study. Arteriosclerosis, thrombosis, and vascular biology 26, 631\u2013636, doi: 10.1161\/01.ATV.0000201289.83256.cf (2006).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"BFsrep33073_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/01.CIR.0000154553.12214.CD","volume":"111","author":"HH Oei","year":"2005","unstructured":"Oei, H. H. et al. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation 111, 570\u2013575, doi: 10.1161\/01.CIR.0000154553.12214.CD (2005).","journal-title":"Circulation"},{"key":"BFsrep33073_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.dadm.2015.08.001","volume":"1","author":"RS Doody","year":"2015","unstructured":"Doody, R. S. et al. Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer\u2019s disease. Alzheimer\u2019s & dementia 1, 464\u2013471, doi: 10.1016\/j.dadm.2015.08.001 (2015).","journal-title":"Alzheimer\u2019s & dementia"},{"key":"BFsrep33073_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/alzrt154","volume":"4","author":"JE Davidson","year":"2012","unstructured":"Davidson, J. E. et al. Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer\u2019s disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study. Alzheimer\u2019s research & therapy 4, 51, doi: 10.1186\/alzrt154 (2012).","journal-title":"Alzheimer\u2019s research & therapy"},{"key":"BFsrep33073_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.atherosclerosis.2008.10.030","volume":"204","author":"R Schnabel","year":"2009","unstructured":"Schnabel, R. et al. Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study. Atherosclerosis 204, 601\u2013607, doi: 10.1016\/j.atherosclerosis.2008.10.030 (2009).","journal-title":"Atherosclerosis"},{"key":"BFsrep33073_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","volume":"24","author":"RM Conroy","year":"2003","unstructured":"Conroy, R. M. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European heart journal 24, 987\u20131003 (2003).","journal-title":"European heart journal"},{"key":"BFsrep33073_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/gerona\/gls187","volume":"68","author":"A Koyama","year":"2013","unstructured":"Koyama, A. et al. The role of peripheral inflammatory markers in dementia and Alzheimer\u2019s disease: a meta-analysis. The journals of gerontology. Series A, Biological sciences and medical sciences 68, 433\u2013440, doi: 10.1093\/gerona\/gls187 (2013).","journal-title":"Series A, Biological sciences and medical sciences"},{"key":"BFsrep33073_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1749-6632.2010.05726.x","volume":"1207","author":"PB Gorelick","year":"2010","unstructured":"Gorelick, P. B. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Annals of the New York Academy of Sciences 1207, 155\u2013162, doi: 10.1111\/j.1749-6632.2010.05726.x (2010).","journal-title":"Annals of the New York Academy of Sciences"},{"key":"BFsrep33073_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1212\/01.WNL.0000158281.08946.68","volume":"64","author":"MG Dik","year":"2005","unstructured":"Dik, M. G. et al. Serum inflammatory proteins and cognitive decline in older persons. Neurology 64, 1371\u20131377, doi: 10.1212\/01.WNL.0000158281.08946.68 (2005).","journal-title":"Neurology"},{"key":"BFsrep33073_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/gerona\/63.1.50","volume":"63","author":"DE Alley","year":"2008","unstructured":"Alley, D. E., Crimmins, E. M., Karlamangla, A., Hu, P. & Seeman, T. E. Inflammation and rate of cognitive change in high-functioning older adults. The journals of gerontology. Series A, Biological sciences and medical sciences 63, 50\u201355 (2008).","journal-title":"The journals of gerontology. Series A, Biological sciences and medical sciences"},{"key":"BFsrep33073_CR17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.psyneuen.2008.07.006","volume":"33","author":"D Gimeno","year":"2008","unstructured":"Gimeno, D., Marmot, M. G. & Singh-Manoux, A. Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology 33, 1322\u20131334, doi: 10.1016\/j.psyneuen.2008.07.006 (2008).","journal-title":"Psychoneuroendocrinology"},{"key":"BFsrep33073_CR18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.dadm.2015.08.001","volume":"1","author":"RS Doody","year":"2015","unstructured":"Doody, R. S. et al. Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring 1, 464\u2013471, doi: 10.1016\/j.dadm.2015.08.001 (2015).","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"BFsrep33073_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2796.2006.01687.x","volume":"260","author":"MJ Stampfer","year":"2006","unstructured":"Stampfer, M. J. Cardiovascular disease and Alzheimer\u2019s disease: common links. Journal of internal medicine 260, 211\u2013223, doi: 10.1111\/j.1365-2796.2006.01687.x (2006).","journal-title":"Journal of internal medicine"},{"key":"BFsrep33073_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.atherosclerosis.2015.05.006","volume":"241","author":"PK Garg","year":"2015","unstructured":"Garg, P. K. et al. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis. Atherosclerosis 241, 176\u2013182, doi: 10.1016\/j.atherosclerosis.2015.05.006 (2015).","journal-title":"Atherosclerosis"},{"key":"BFsrep33073_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/STROKEAHA.107.513259","volume":"40","author":"V Nambi","year":"2009","unstructured":"Nambi, V. et al. Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study. Stroke; a journal of cerebral circulation 40, 376\u2013381, doi: 10.1161\/STROKEAHA.107.513259 (2009).","journal-title":"Stroke; a journal of cerebral circulation"},{"key":"BFsrep33073_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3233\/JAD-143096","volume":"46","author":"T Bacchetti","year":"2015","unstructured":"Bacchetti, T. et al. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer\u2019s Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1. Journal of Alzheimer\u2019s disease: JAD 46, 179\u2013186, doi: 10.3233\/JAD-143096 (2015).","journal-title":"Journal of Alzheimer\u2019s disease: JAD"},{"key":"BFsrep33073_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1124\/dmd.113.054486","volume":"42","author":"M Dave","year":"2014","unstructured":"Dave, M. et al. Disposition and metabolism of darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in humans. Drug metabolism and disposition: the biological fate of chemicals 42, 415\u2013430, doi: 10.1124\/dmd.113.054486 (2014).","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"key":"BFsrep33073_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.arr.2009.07.005","volume":"9","author":"V Solfrizzi","year":"2010","unstructured":"Solfrizzi, V. et al. Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms. Ageing research reviews 9, 184\u2013199, doi: 10.1016\/j.arr.2009.07.005 (2010).","journal-title":"Ageing research reviews"},{"key":"BFsrep33073_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.arr.2010.04.007","volume":"9","author":"V Frisardi","year":"2010","unstructured":"Frisardi, V. et al. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer\u2019s disease. Ageing research reviews 9, 399\u2013417, doi: 10.1016\/j.arr.2010.04.007 (2010).","journal-title":"Ageing research reviews"},{"key":"BFsrep33073_CR26","doi-asserted-by":"crossref","unstructured":"Li, H., Jia, J. & Yang, Z. Mini-Mental State Examination in Elderly Chinese: A Population-Based Normative Study. Journal of Alzheimer\u2019s disease: JAD, doi: 10.3233\/JAD-160119 (2016).","DOI":"10.3233\/JAD-160119"},{"key":"BFsrep33073_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1161\/CIRCOUTCOMES.111.963694","volume":"5","author":"S Wu","year":"2012","unstructured":"Wu, S. et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circulation. Cardiovascular quality and outcomes 5, 487\u2013493, doi: 10.1161\/CIRCOUTCOMES.111.963694 (2012).","journal-title":"Circulation. Cardiovascular quality and outcomes"},{"key":"BFsrep33073_CR28","doi-asserted-by":"publisher","first-page":"e84685","DOI":"10.1371\/journal.pone.0084685","volume":"8","author":"Y Zhou","year":"2013","unstructured":"Zhou, Y. et al. Asymptomatic polyvascular abnormalities in community (APAC) study in China: objectives, design and baseline characteristics. PloS one 8, e84685, doi: 10.1371\/journal.pone.0084685 (2013).","journal-title":"PloS one"},{"key":"BFsrep33073_CR29","doi-asserted-by":"publisher","first-page":"e61665","DOI":"10.1371\/journal.pone.0061665","volume":"8","author":"A Wang","year":"2013","unstructured":"Wang, A. et al. Measures of adiposity and risk of stroke in China: a result from the Kailuan study. PloS one 8, e61665, doi: 10.1371\/journal.pone.0061665 (2013).","journal-title":"PloS one"},{"key":"BFsrep33073_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. Journal of psychiatric research 12, 189\u2013198 (1975).","journal-title":"Journal of psychiatric research"},{"key":"BFsrep33073_CR31","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jamainternmed.2015.2152","volume":"175","author":"KK Tsoi","year":"2015","unstructured":"Tsoi, K. K., Chan, J. Y., Hirai, H. W., Wong, S. Y. & Kwok, T. C. Cognitive Tests to Detect Dementia: A Systematic Review and Meta-analysis. JAMA internal medicine 175, 1450\u20131458, doi: 10.1001\/jamainternmed.2015.2152 (2015).","journal-title":"JAMA internal medicine"},{"key":"BFsrep33073_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.hrtlng.2012.11.003","volume":"42","author":"KK Davis","year":"2013","unstructured":"Davis, K. K. & Allen, J. K. Identifying cognitive impairment in heart failure: a review of screening measures. Heart & lung: the journal of critical care 42, 92\u201397, doi: 10.1016\/j.hrtlng.2012.11.003 (2013).","journal-title":"Heart & lung: the journal of critical care"},{"key":"BFsrep33073_CR33","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1161\/STROKEAHA.114.005842","volume":"45","author":"R Lees","year":"2014","unstructured":"Lees, R. et al. Test accuracy of cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke. Stroke; a journal of cerebral circulation 45, 3008\u20133018, doi: 10.1161\/STROKEAHA.114.005842 (2014).","journal-title":"Stroke; a journal of cerebral circulation"},{"key":"BFsrep33073_CR34","doi-asserted-by":"publisher","first-page":"e65229","DOI":"10.1371\/journal.pone.0065229","volume":"8","author":"J Wu","year":"2013","unstructured":"Wu, J. et al. Association between non-high-density-lipoprotein-cholesterol levels and the prevalence of asymptomatic intracranial arterial stenosis. PloS one 8, e65229, doi: 10.1371\/journal.pone.0065229 (2013).","journal-title":"PloS one"},{"key":"BFsrep33073_CR35","doi-asserted-by":"publisher","first-page":"10003","DOI":"10.1038\/srep10003","volume":"5","author":"Q Li","year":"2015","unstructured":"Li, Q. et al. The Association between Serum Uric Acid Levels and the Prevalence of Vulnerable Atherosclerotic Carotid Plaque: A Cross-sectional Study. Scientific reports 5, 10003, doi: 10.1038\/srep10003 (2015).","journal-title":"Scientific reports"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep33073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33073","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:52:38Z","timestamp":1672879958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep33073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep33073"],"URL":"https:\/\/doi.org\/10.1038\/srep33073","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]},"assertion":[{"value":"11 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33073"}}